Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Hemmings and Platholi Labs
Explore this Website
Home
Research
Toggle Research menu options
Dr. Hemmings' Research Projects
Toggle Dr. Hemmings' Research Projects menu options
Interneuron diversity
Sodium channels as anesthetic targets
Volatile anesthetic effects on intracellular Ca2+ dynamics influence synaptic vesicle exocytosis
Volatile anesthetics directly bind Nav
Dr. Platholi's Research Projects
Toggle Dr. Platholi's Research Projects menu options
Role of genetic polymorphisms in anesthetic-induced effects on synaptic function and structure.
Spine plasticity in anesthetic action
Voltage gated sodium channels (Nav) and hyperexcitability in early Alzheimer Disease.
Lab Teams
Publications
Join Us
Toggle Join Us menu options
Collaborators
Job Opportunities
Weill Cornell Medicine
Care
Discover
Teach
Home
Research
Lab Teams
Publications
Join Us
Home
Publications
Publications
Found 42 results
Author
Title
Type
Year
Filters:
First Letter Of Last Name
is
W
[Clear All Filters]
2004
Ouyang W, Wang G, Hemmings HC
. 2004.
Distinct rat neurohypophysial nerve terminal populations identified by size, electrophysiological properties and neuropeptide content.
.
Brain Res. 1024(1-2):203-11.
2003
Westphalen RI, Hemmings HC
. 2003.
Effects of isoflurane and propofol on glutamate and GABA transporters in isolated cortical nerve terminals.
.
Anesthesiology. 98(2):364-72.
OuYang W, Wang G, Hemmings HC
. 2003.
Isoflurane and propofol inhibit voltage-gated sodium channels in isolated rat neurohypophysial nerve terminals.
.
Mol Pharmacol. 64(2):373-81.
Westphalen RI, Hemmings HC
. 2003.
Selective depression by general anesthetics of glutamate versus GABA release from isolated cortical nerve terminals.
.
J Pharmacol Exp Ther. 304(3):1188-96.
2002
Pashkov VN, Westphalen RI, Hemmings HC
. 2002.
General anesthetics do not affect release of the neuropeptide cholecystokinin from isolated rat cortical nerve terminals.
.
Anesthesiology. 97(6):1500-6.
1996
Wei L, Schlame M, Downes H, Hemmings HC
. 1996.
CHEB, a convulsant barbiturate, evokes calcium-dependent spontaneous glutamate release from rat cerebrocortical synaptosomes.
.
Neuropharmacology. 35(6):695-701.
1990
Girault JA, Walaas SI, Hemmings HC, Greengard P
. 1990.
ARPP-21, a cAMP-regulated phosphoprotein enriched in dopamine-innervated brain regions: tissue distribution and regulation of phosphorylation in rat brain.
.
Neuroscience. 37(2):317-25.
1989
Williams KR, Hemmings HC, LoPresti MB, Greengard P
. 1989.
ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Amino acid sequence of ARPP-21B from bovine caudate nucleus.
.
J Neurosci. 9(10):3631-7.
Hemmings HC, Girault JA, Williams KR, LoPresti MB, Greengard P
. 1989.
ARPP-21, a cyclic AMP-regulated phosphoprotein (Mr = 21,000) enriched in dopamine-innervated brain regions. Amino acid sequence of the site phosphorylated by cyclic AMP in intact cells and kinetic studies of its phosphorylation in vitro.
.
J Biol Chem. 264(13):7726-33.
Girault JA, Hemmings HC, Williams KR, Nairn AC, Greengard P
. 1989.
Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II.
.
J Biol Chem. 264(36):21748-59.
1988
Nairn AC, Hemmings HC, Walaas SI, Greengard P
. 1988.
DARPP-32 and phosphatase inhibitor-1, two structurally related inhibitors of protein phosphatase-1, are both present in striatonigral neurons.
.
J Neurochem. 50(1):257-62.
Agnati LF, Fuxe K, Zoli M, Ferraguti F, Benfenati F, Ouimet CC, Walaas SI, Hemmings HC, Goldstein M, Greengard P
. 1988.
Morphometrical evidence for a complex organization of tyrosine hydroxylase-, enkephalin- and DARPP-32-like immunoreactive patches and their codistribution at three rostrocaudal levels in the rat neostriatum.
.
Neuroscience. 27(3):785-97.
Foster GA, Schultzberg M, Kökfelt T, Goldstein M, Hemmings HC, Ouimet CC, Walaas SI, Greengard P
. 1988.
Ontogeny of the dopamine and cyclic adenosine-3':5'-monophosphate-regulated phosphoprotein (DARPP-32) in the pre- and postnatal mouse central nervous system.
.
Int J Dev Neurosci. 6(4):367-86.
1987
Foster GA, Schultzberg M, Hökfelt T, Goldstein M, Hemmings HC, Ouimet CC, Walaas SI, Greengard P
. 1987.
Development of a dopamine- and cyclic adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) in the prenatal rat central nervous system, and its relationship to the arrival of presumptive dopaminergic innervation.
.
J Neurosci. 7(7):1994-2018.
1986
Williams KR, Hemmings HC, LoPresti MB, Konigsberg WH, Greengard P
. 1986.
DARPP-32, a dopamine- and cyclic AMP-regulated neuronal phosphoprotein. Primary structure and homology with protein phosphatase inhibitor-1.
.
J Biol Chem. 261(4):1890-903.
1984
Hemmings HC, Williams KR, Konigsberg WH, Greengard P
. 1984.
DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated neuronal phosphoprotein. I. Amino acid sequence around the phosphorylated threonine.
.
J Biol Chem. 259(23):14486-90.
Ouimet CC, Miller PE, Hemmings HC, Walaas SI, Greengard P
. 1984.
DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization.
.
J Neurosci. 4(1):111-24.
« first
‹ previous
1
2
(current)